Press Releases Archives - Page 71 of 103 - Lupin

BSE 2302.10 NSE 2302.70

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2302.10 NSE 2302.70

Lupin Receives Tentative Approval for Generic Zorvolex® Capsules

December 6, 2016

Lupin Receives FDA Approval for Generic Norco® Tablets

December 5, 2016

Lupin and Eli Lilly Expand Partnership in India

December 1, 2016

Lupin Receives FDA Approval for Generic Nuvigil® Tablets

November 29, 2016

Lupin Receives Tentative Approval for Generic Epzicom® Tablets

November 23, 2016

Lupin Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets

November 17, 2016

Lupin Launches Generic Activella® Tablets in the US

November 15, 2016

Lupin Launches Novel Injectable Iron Formulation Under Brand Names “ISOFER” and “JILAZO” in India

November 11, 2016

Lupin’s Quarter II, FY2017 – Results

November 9, 2016

Lupin receives EIR from US FDA for Goa, March 2016 Inspection

November 4, 2016

1 2 … 70 71 72 … 102 103

Search

Hit enter to search or ESC to close